34 results on '"Lucas, R."'
Search Results
2. Gut microbiome transitions across generations in different ethnicities in an urban setting—the HELIUS study
- Author
-
van der Vossen, Eduard W. J., Davids, Mark, Bresser, Lucas R. F., Galenkamp, Henrike, van den Born, Bert-Jan H., Zwinderman, Aeilko H., Levin, Evgeni, Nieuwdorp, Max, and de Goffau, Marcus C.
- Published
- 2023
- Full Text
- View/download PDF
3. Comparing Sugarbaker versus keyhole mesh technique for open retromuscular parastomal hernia repair: study protocol for a registry-based randomized controlled trial
- Author
-
Miller, Benjamin T., Thomas, Jonah D., Tu, Chao, Costanzo, Adele, Beffa, Lucas R. A., Krpata, David M., Prabhu, Ajita S., Rosen, Michael J., and Petro, Clayton C.
- Published
- 2022
- Full Text
- View/download PDF
4. Human in silico trials for parametric computational fluid dynamics investigation of cerebrospinal fluid drug delivery: impact of injection location, injection protocol, and physiology
- Author
-
Khani, Mohammadreza, Burla, Goutham Kumar Reddy, Sass, Lucas R., Arters, Ostin N., Xing, Tao, Wu, Haiming, and Martin, Bryn A.
- Published
- 2022
- Full Text
- View/download PDF
5. StrainGE: a toolkit to track and characterize low-abundance strains in complex microbial communities
- Author
-
van Dijk, Lucas R., Walker, Bruce J., Straub, Timothy J., Worby, Colin J., Grote, Alexandra, Schreiber, IV, Henry L., Anyansi, Christine, Pickering, Amy J., Hultgren, Scott J., Manson, Abigail L., Abeel, Thomas, and Earl, Ashlee M.
- Published
- 2022
- Full Text
- View/download PDF
6. The economic burden of malaria: a systematic review
- Author
-
Andrade, Mônica V., Noronha, Kenya, Diniz, Bernardo P. C., Guedes, Gilvan, Carvalho, Lucas R., Silva, Valéria A., Calazans, Júlia A., Santos, André S., Silva, Daniel N., and Castro, Marcia C.
- Published
- 2022
- Full Text
- View/download PDF
7. Soft robotics and functional electrical stimulation advances for restoring hand function in people with SCI: a narrative review, clinical guidelines and future directions
- Author
-
Cardoso, Lucas R. L., Bochkezanian, Vanesa, Forner-Cordero, Arturo, Melendez-Calderon, Alejandro, and Bo, Antonio P. L.
- Published
- 2022
- Full Text
- View/download PDF
8. Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences
- Author
-
Eng, Alexander, Hayden, Hillary S., Pope, Christopher E., Brittnacher, Mitchell J., Vo, Anh T., Weiss, Eli J., Hager, Kyle R., Leung, Daniel H., Heltshe, Sonya L., Raftery, Daniel, Miller, Samuel I., Hoffman, Lucas R., and Borenstein, Elhanan
- Published
- 2021
- Full Text
- View/download PDF
9. Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations
- Author
-
Cusumano, Lucas R., Tesoriero, Joseph A., Wilsen, Craig B., Sayre, James, Quirk, Matthew, and McWilliams, Justin P.
- Published
- 2021
- Full Text
- View/download PDF
10. Microfluidic guillotine reveals multiple timescales and mechanical modes of wound response in Stentor coeruleus
- Author
-
Zhang, Kevin S., Blauch, Lucas R., Huang, Wesley, Marshall, Wallace F., and Tang, Sindy K. Y.
- Published
- 2021
- Full Text
- View/download PDF
11. Lung function and microbiota diversity in cystic fibrosis
- Author
-
Cuthbertson, Leah, Walker, Alan W., Oliver, Anna E., Rogers, Geraint B., Rivett, Damian W., Hampton, Thomas H., Ashare, Alix, Elborn, J. Stuart, De Soyza, Anthony, Carroll, Mary P., Hoffman, Lucas R., Lanyon, Clare, Moskowitz, Samuel M., O’Toole, George A., Parkhill, Julian, Planet, Paul J., Teneback, Charlotte C., Tunney, Michael M., Zuckerman, Jonathan B., Bruce, Kenneth D., and van der Gast, Christopher J.
- Published
- 2020
- Full Text
- View/download PDF
12. In vitro and numerical simulation of blood removal from cerebrospinal fluid: comparison of lumbar drain to Neurapheresis therapy
- Author
-
Khani, Mohammadreza, Sass, Lucas R., Sharp, M. Keith, McCabe, Aaron R., Zitella Verbick, Laura M., Lad, Shivanand P., and Martin, Bryn A.
- Published
- 2020
- Full Text
- View/download PDF
13. Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients
- Author
-
Sass, Lucas R., Khani, Mohammadreza, Romm, Jacob, Schmid Daners, Marianne, McCain, Kyle, Freeman, Tavara, Carter, Gregory T., Weeks, Douglas L., Petersen, Brian, Aldred, Jason, Wingett, Dena, and Martin, Bryn A.
- Published
- 2020
- Full Text
- View/download PDF
14. How low can we go? The implications of low bacterial load in respiratory microbiota studies
- Author
-
Marsh, Robyn L., Nelson, Maria T., Pope, Chris E., Leach, Amanda J., Hoffman, Lucas R., Chang, Anne B., and Smith-Vaughan, Heidi C.
- Published
- 2018
- Full Text
- View/download PDF
15. A comprehensive urban programme to reduce energy poverty and its effects on health and wellbeing of citizens in six European countries: study protocol of a controlled trial
- Author
-
Stevens, M, Raat, H, Ferrando, M, Vallina, B, Lucas, R, Middlemiss, L, Rédon, J, Rocher, E, van Grieken, A, and Public Health
- Subjects
Health-related quality of life ,Public Health, Environmental and Occupational Health ,Energy poverty ,United Kingdom ,SDG 11 - Sustainable Cities and Communities ,Europe ,Health inequity ,Mental Health ,SDG 3 - Good Health and Well-being ,Quality of Life ,Social-ecological model ,Humans ,Multicenter Studies as Topic ,Controlled Clinical Trials as Topic ,SDG 7 - Affordable and Clean Energy ,Poverty ,Aged - Abstract
Background Nearly 11% of the European population is affected by energy poverty. Energy poverty is defined by the European Commission (2016) as the inability to afford basic energy services to guarantee a decent standard of living. Energy poverty is considered a complex, multidimensional problem that affects environment, housing, urban development, and health. Living in energy poverty conditions is associated with poorer human health and wellbeing. Hence, the WELLBASED intervention programme aims to design, implement and evaluate a comprehensive urban programme, based on the social-ecological model, to reduce energy poverty and its effects on the citizens’ health and wellbeing in six European urban study sites: Valencia, Spain; Heerlen, The Netherlands; Leeds, United Kingdom; Edirne, Turkey; Obuda, Hungary, and; Jelgava, Latvia. Methods A controlled trial is performed. A total of 875 participants are recruited (125–177 per study site) to receive the WELLBASED intervention programme for 12 months (intervention condition) and 875 participants act as controls (control condition). Data will be collected with a baseline measurement at inclusion (T0), and follow-up measurements after 6 months (T1), 12 months (T2), and 18 months (T3). In both study arms, effects of the WELLBASED intervention programme are measured: health-related quality of life (HR-QoL), mental health, frailty in older adults, self-perceived health, chronic conditions, and care utilization. At the same time points, household expenditure on energy and energy consumption are obtained. In the intervention arm, health-monitoring data (i.e. peak flow, oxygen saturation, blood pressure, and heart rate) are obtained monthly and sleep quality with a three-month interval. Household data with regard to temperature, humidity and air quality are collected near real-time by home sensors. Qualitative interviews are conducted in each study site to evaluate the impacts of the WELLBASED intervention programme and to help explain findings. Discussion The WELLBASED intervention programme will provide new insights into the effectiveness of a comprehensive urban programme to tackle energy poverty and its effects on health and wellbeing across Europe. Hence, this study can contribute to European-wide replicable solutions for policy-makers and city practitioners to alleviate energy poverty. Trial registration ISRCTN registry number is ISRCTN14905838. Date of registration is 15/02/2022.
- Published
- 2022
16. Human in silico trials for parametric computational fluid dynamics investigation of cerebrospinal fluid drug delivery: impact of injection location, injection protocol, and physiology
- Author
-
Ostin N. Arters, Tao Xing, Lucas R. Sass, Bryn A. Martin, Goutham Kumar Reddy Burla, Mohammadreza Khani, and Haiming Wu
- Subjects
Multiphase solute transport ,Computer science ,In silico ,Computational biology ,Computational fluid dynamics ,Cellular and Molecular Neuroscience ,Cerebrospinal fluid ,Magnetic resonance imaging ,Drug Delivery Systems ,Developmental Neuroscience ,In vitro model ,Cisterna Magna ,Humans ,Biomechanics ,Computer Simulation ,RC346-429 ,Injections, Spinal ,Parametric statistics ,Injections, Intraventricular ,Protocol (science) ,business.industry ,Research ,Ventricular drug delivery ,General Medicine ,Models, Theoretical ,Intrathecal drug delivery ,Neurology ,Central nervous system ,Drug delivery ,Hydrodynamics ,Neurology. Diseases of the nervous system ,business ,Biofluid mechanics ,Cisterna magna drug delivery - Abstract
Background Intrathecal drug delivery has a significant role in pain management and central nervous system (CNS) disease therapeutics. A fluid-physics based tool to assist clinicians in choosing specific drug doses to the spine or brain may help improve treatment schedules. Methods This study applied computational fluid dynamics (CFD) and in vitro model verification to assess intrathecal drug delivery in an anatomically idealized model of the human CSF system with key anatomic features of the CNS. Key parameters analyzed included the role of (a) injection location including lumbar puncture (LP), cisterna magna (CM) and intracerebroventricular (ICV), (b) LP injection rate, injection volume, and flush volume, (c) physiologic factors including cardiac-induced and deep respiration-induced CSF stroke volume increase. Simulations were conducted for 3-h post-injection and used to quantify spatial–temporal tracer concentration, regional area under the curve (AUC), time to maximum concentration (Tmax), and maximum concentration (Cmax), for each case. Results CM and ICV increased AUC to brain regions by ~ 2 logs compared to all other simulations. A 3X increase in bolus volume and addition of a 5 mL flush both increased intracranial AUC to the brain up to 2X compared to a baseline 5 mL LP injection. In contrast, a 5X increase in bolus rate (25 mL/min) did not improve tracer exposure to the brain. An increase in cardiac and respiratory CSF movement improved tracer spread to the brain, basal cistern, and cerebellum up to ~ 2 logs compared to the baseline LP injection. Conclusion The computational modeling approach provides ability to conduct in silico trials representative of CSF injection protocols. Taken together, the findings indicate a strong potential for delivery protocols to be optimized to reach a target region(s) of the spine and/or brain with a needed therapeutic dose. Parametric modification of bolus rate/volume and flush volume was found to have impact on tracer distribution; albeit to a smaller degree than injection location, with CM and ICV injections resulting in greater therapeutic dose to brain regions compared to LP. CSF stroke volume and frequency both played an important role and may potentially have a greater impact than the modest changes in LP injection protocols analyzed such as bolus rate, volume, and flush.
- Published
- 2022
17. Predictors of heart failure symptoms in hereditary hemorrhagic telangiectasia patients with hepatic arteriovenous malformations
- Author
-
James Sayre, Joseph A Tesoriero, Craig B. Wilsen, Matthew Quirk, Lucas R. Cusumano, and Justin P. McWilliams
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Liver transplantation ,Cardiovascular ,Asymptomatic ,Gastroenterology ,Arteriovenous Malformations ,Cohort Studies ,Common hepatic artery ,Internal medicine ,medicine.artery ,medicine ,Humans ,Pharmacology (medical) ,Telangiectasia ,Hereditary Hemorrhagic ,Computed tomography ,Genetics (clinical) ,Hereditary Hemorrhagic Telangiectasia ,High-output heart failure ,Computed tomography angiography ,Pediatric ,Genetics & Heredity ,Heart Failure ,Other Medical and Health Sciences ,medicine.diagnostic_test ,business.industry ,Research ,Liver Diseases ,General Medicine ,Hematology ,medicine.disease ,medicine.anatomical_structure ,Heart Disease ,Heart failure ,Congenital Structural Anomalies ,Medicine ,Telangiectasia, Hereditary Hemorrhagic ,medicine.symptom ,business ,Digestive Diseases ,Artery - Abstract
Background Hepatic arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia (HHT) patients are most commonly hepatic artery to hepatic venous shunts which can result in high-output heart failure. This condition can be debilitating and is a leading cause of liver transplantation in HHT patients. However, it is not known what characteristics can discriminate between asymptomatic patients and those who will develop heart failure symptoms. Results 176 patients with HHT were evaluated with computed tomography angiography (CTA) between April 2004 and February 2019 at our HHT Center of Excellence. 63/176 (35.8%) patients were found to have hepatic AVMs on CTA. 18 of these patients were excluded because of the presence of another condition which could confound evaluation of heart failure symptoms. In the remaining 45 patients included in our cohort, 25/45 (55.6%) patients were classified as asymptomatic and 20/45 (44.4%) were classified as symptomatic, and these groups were compared. In symptomatic patients, mean common hepatic artery (CHA) diameter was significantly higher (11.1 versus 8.4 mm) and mean hemoglobin levels were significantly lower (10.7 vs 12.6 g/dL). A stepwise multiple logistic regression analysis demonstrated that both CHA diameter and hemoglobin level were independent predictors of heart failure symptoms with ORs of 2.554 (95% CI 1.372–4.754) and 0.489 (95% CI 0.299–0.799), respectively. The receiver operator characteristic (ROC) curve of our analysis demonstrated an AUC of 0.906 (95% CI 0.816–0.996), sensitivity 80.0% (95% CI 55.7–93.4%), and specificity 75.0% (95% CI 52.9–89.4%). Conclusions CTA is an effective and easily reproducible method to evaluate hepatic involvement of HHT. Utilizing CTA, clinical, and laboratory data we determined CHA diameter and hemoglobin level were independent predictors of heart failure symptoms.
- Published
- 2021
18. Transcranial direct current stimulation (tDCS) in addition to walking training on walking, mobility, and reduction of falls in Parkinson’s disease: study protocol for a randomized clinical trial
- Author
-
Bárbara Naeme Lima Cordeiro, Guilherme Peixoto Tinoco Arêas, Wellingson Silva Paiva, Daniel Lyrio Cabral, Lucas R. Nascimento, Ester Miyuki Nakamura-Palacios, Alessandra Swarowsky, Augusto Boening, and Fernando Zanela da Silva Arêas
- Subjects
Medicine (General) ,medicine.medical_specialty ,Parkinson's disease ,medicine.medical_treatment ,Medicine (miscellaneous) ,law.invention ,Study Protocol ,R5-920 ,Physical medicine and rehabilitation ,Randomized controlled trial ,law ,medicine ,Pharmacology (medical) ,Parkinson ,Gait ,Rehabilitation ,Transcranial direct-current stimulation ,business.industry ,medicine.disease ,Clinical trial ,Transcranial direct current stimulation ,business ,human activities - Abstract
Background Transcranial direct current stimulation (tDCS) has the potential to modulate cortical excitability and enhance the effects of walking training in people with Parkinson’s disease. This study will examine the efficacy of the addition of tDCS to a task-specific walking training to improve walking and mobility and to reduce falls in people with Parkinson’s disease. Methods This is a two-arm, prospectively registered, randomized trial with concealed allocation, blinded assessors, participants and therapists, and intention-to-treat analysis. Twenty-four individuals with Parkinson’s disease, categorized as slow or intermediate walkers (walking speeds ≤ 1.0 m/s), will be recruited. The experimental group will undertake a 30-min walking training associated with tDCS, for 4 weeks. The control group will undertake the same walking training, but with sham-tDCS. The primary outcome will be comfortable walking speed. Secondary outcomes will include walking step length, walking cadence, walking confidence, mobility, freezing of gait, fear of falling, and falls. Outcomes will be collected by a researcher blinded to group allocation at baseline (week 0), after intervention (week 4), and 1 month beyond intervention (week 8). Discussion tDCS associated with walking training may help improve walking of slow and intermediate walkers with Parkinson’s disease. If walking is enhanced, the benefits may be accompanied by better mobility and reduced fear of falling, and individuals may experience greater free-living physical activity at home and in the community. Trial registration Brazilian Registry of Clinical Trials (ReBEC) RBR-6bvnx6. Registered on September 23, 2019
- Published
- 2021
19. Lung function and microbiota diversity in cystic fibrosis
- Author
-
Lucas R. Hoffman, George A. O'Toole, Samuel M. Moskowitz, Paul J. Planet, Damian W. Rivett, Charlotte C. Teneback, Anthony De Soyza, Christopher J. van der Gast, Mary P. Carroll, Kenneth D. Bruce, Jonathan B. Zuckerman, Alan W. Walker, Alix Ashare, Anna Oliver, Thomas H. Hampton, J. Stuart Elborn, Michael M. Tunney, Geraint B. Rogers, Leah Cuthbertson, Clare Lanyon, Julian Parkhill, Apollo - University of Cambridge Repository, and Parkhill, Julian [0000-0002-7069-5958]
- Subjects
Male ,Cystic Fibrosis ,Disease ,Cystic fibrosis ,Lung microbiome ,Medical microbiology ,Antibiotics ,Lung ,0303 health sciences ,Microbiota ,C500 ,respiratory system ,Anti-Bacterial Agents ,Respiratory Function Tests ,3. Good health ,Europe ,medicine.anatomical_structure ,Biogeography ,Health ,Disease Progression ,lcsh:QR100-130 ,Female ,medicine.symptom ,Adult ,Microbiology (medical) ,medicine.medical_specialty ,B100 ,Biology ,Microbiology ,lcsh:Microbial ecology ,Ecological patterns ,Young Adult ,03 medical and health sciences ,medicine ,Microbial surveillance ,Humans ,Microbiome ,Disease severity ,030304 developmental biology ,Inflammation ,Bacteria ,030306 microbiology ,Research ,Sputum ,Sequence Analysis, DNA ,A300 ,medicine.disease ,Lung function ,United States ,respiratory tract diseases ,Chronic infection ,Immunology ,Lung microbiota - Abstract
BackgroundChronic infection and concomitant airway inflammation is the leading cause of morbidity and mortality for people living with cystic fibrosis (CF). Although chronic infection in CF is undeniably polymicrobial, involving a lung microbiota, infection surveillance and control approaches remain underpinned by classical aerobic culture-based microbiology. How to use microbiomics to direct clinical management of CF airway infections remains a crucial challenge. A pivotal step towards leveraging microbiome approaches in CF clinical care is to understand the ecology of the CF lung microbiome and identify ecological patterns of CF microbiota across a wide spectrum of lung disease. Assessing sputum samples from 299 patients attending 13 CF centres in Europe and the USA, we determined whether the emerging relationship of decreasing microbiota diversity with worsening lung function could be considered a generalised pattern of CF lung microbiota and explored its potential as an informative indicator of lung disease state in CF.ResultsWe tested and found decreasing microbiota diversity with a reduction in lung function to be a significant ecological pattern. Moreover, the loss of diversity was accompanied by an increase in microbiota dominance. Subsequently, we stratified patients into lung disease categories of increasing disease severity to further investigate relationships between microbiota characteristics and lung function, and the factors contributing to microbiota variance. Core taxa group composition became highly conserved within the severe disease category, while the rarer satellite taxa underpinned the high variability observed in the microbiota diversity. Further, the lung microbiota of individual patient were increasingly dominated by recognised CF pathogens as lung function decreased. Conversely, other bacteria, especially obligate anaerobes, increasingly dominated in those with better lung function. Ordination analyses revealed lung function and antibiotics to be main explanators of compositional variance in the microbiota and the core and satellite taxa. Biogeography was found to influence acquisition of the rarer satellite taxa.ConclusionsOur findings demonstrate that microbiota diversity and dominance, as well as the identity of the dominant bacterial species, in combination with measures of lung function, can be used as informative indicators of disease state in CF.
- Published
- 2020
20. Influencing the secretion of myogenic factors from mesenchymal stem cells
- Author
-
Smith, Lucas R
- Published
- 2014
- Full Text
- View/download PDF
21. A 3D subject-specific model of the spinal subarachnoid space with anatomically realistic ventral and dorsal spinal cord nerve rootlets.
- Author
-
Sass, Lucas R., Khani, Mohammadreza, Natividad, Gabryel Connely, Tubbs, R. Shane, Baledent, Olivier, and Martin, Bryn A.
- Subjects
- *
NEUROLOGICAL disorders , *CEREBROSPINAL fluid , *NEUROSURGERY , *SPINAL cord , *MAGNETIC resonance imaging - Abstract
Background: The spinal subarachnoid space (SSS) has a complex 3D fluid-filled geometry with multiple levels of anatomic complexity, the most salient features being the spinal cord and dorsal and ventral nerve rootlets. An accurate anthropomorphic representation of these features is needed for development of in vitro and numerical models of cerebrospinal fluid (CSF) dynamics that can be used to inform and optimize CSF-based therapeutics. Methods: A subject-specific 3D model of the SSS was constructed based on high-resolution anatomic MRI. An expert operator completed manual segmentation of the CSF space with detailed consideration of the anatomy. 31 pairs of semi-idealized dorsal and ventral nerve rootlets (NR) were added to the model based on anatomic reference to the magnetic resonance (MR) imaging and cadaveric measurements in the literature. Key design criteria for each NR pair included the radicular line, descending angle, number of NR, attachment location along the spinal cord and exit through the dura mater. Model simplification and smoothing was performed to produce a final model with minimum vertices while maintaining minimum error between the original segmentation and final design. Final model geometry and hydrodynamics were characterized in terms of axial distribution of Reynolds number, Womersley number, hydraulic diameter, cross-sectional area and perimeter. Results: The final model had a total of 139,901 vertices with a total CSF volume within the SSS of 97.3 cm3. Volume of the dura mater, spinal cord and NR was 123.1, 19.9 and 5.8 cm3. Surface area of these features was 318.52, 112.2 and 232.1 cm2 respectively. Maximum Reynolds number was 174.9 and average Womersley number was 9.6, likely indicating presence of a laminar inertia-dominated oscillatory CSF flow field. Conclusions: This study details an anatomically realistic anthropomorphic 3D model of the SSS based on high-resolution MR imaging of a healthy human adult female. The model is provided for re-use under the Creative Commons Attribution-ShareAlike 4.0 International license (CC BY-SA 4.0) and can be used as a tool for development of in vitro and numerical models of CSF dynamics for design and optimization of intrathecal therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
22. SMASH -- semi-automatic muscle analysis using segmentation of histology: a MATLAB application.
- Author
-
Smith, Lucas R. and Barton, Elisabeth R.
- Subjects
- *
SKELETAL muscle , *PHYSIOLOGICAL research , *MUSCLE diseases , *MUSCLE injuries , *MUSCLES - Abstract
Background Histological assessment of skeletal muscle tissue is commonly applied to many areas of skeletal muscle physiological research. Histological parameters including fiber distribution, fiber type, centrally nucleated fibers, and capillary density are all frequently quantified measures of skeletal muscle. These parameters reflect functional properties of muscle and undergo adaptation in many muscle diseases and injuries. While standard operating procedures have been developed to guide analysis of many of these parameters, the software to freely, efficiently, and consistently analyze them is not readily available. In order to provide this service to the muscle research community we developed an open source MATLAB script to analyze immunofluorescent muscle sections incorporating user controls for muscle histological analysis. Results The software consists of multiple functions designed to provide tools for the analysis selected. Initial segmentation and fiber filter functions segment the image and remove nonfiber elements based on user-defined parameters to create a fiber mask. Establishing parameters set by the user, the software outputs data on fiber size and type, centrally nucleated fibers, and other structures. These functions were evaluated on stained soleus muscle sections from 1-year-old wild-type and mdx mice, a model of Duchenne muscular dystrophy. In accordance with previously published data, fiber size was not different between groups, but mdx muscles had much higher fiber size variability. The mdx muscle had a significantly greater proportion of type I fibers, but type I fibers did not change in size relative to type II fibers. Centrally nucleated fibers were highly prevalent in mdx muscle and were significantly larger than peripherally nucleated fibers. Conclusions The MATLAB code described and provided along with this manuscript is designed for image processing of skeletal muscle immunofluorescent histological sections. The program allows for semi-automated fiber detection along with user correction. The output of the code provides data in accordance with established standards of practice. The results of the program have been validated using a small set of wild-type and mdx muscle sections. This program is the first freely available and open source image processing program designed to automate analysis of skeletal muscle histological sections. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
23. Navigating geographical disparities: access to obstetric hospitals in maternity care deserts and across the United States.
- Author
-
Fontenot J, Brigance C, Lucas R, and Stoneburner A
- Subjects
- Humans, United States, Female, Pregnancy, Retrospective Studies, Travel statistics & numerical data, Rural Population statistics & numerical data, Health Services Accessibility statistics & numerical data, Healthcare Disparities statistics & numerical data, Healthcare Disparities ethnology, Maternal Health Services statistics & numerical data, Hospitals, Maternity statistics & numerical data
- Abstract
Background: Access to maternity care in the U.S. remains inequitable, impacting over two million women in maternity care "deserts." Living in these areas, exacerbated by hospital closures and workforce shortages, heightens the risks of pregnancy-related complications, particularly in rural regions. This study investigates travel distances and time to obstetric hospitals, emphasizing disparities faced by those in maternity care deserts and rural areas, while also exploring variances across races and ethnicities., Methods: The research adopted a retrospective secondary data analysis, utilizing the American Hospital Association and Centers for Medicaid and Medicare Provider of Services Files to classify obstetric hospitals. The study population included census tract estimates of birthing individuals sourced from the U.S. Census Bureau's 2017-2021 American Community Survey. Using ArcGIS Pro Network Analyst, drive time and distance calculations to the nearest obstetric hospital were conducted. Furthermore, Hot Spot Analysis was employed to identify areas displaying significant spatial clusters of high and low travel distances., Results: The mean travel distance and time to the nearest obstetric facility was 8.3 miles and 14.1 minutes. The mean travel distance for maternity care deserts and rural counties was 28.1 and 17.3 miles, respectively. While birthing people living in rural maternity care deserts had the highest average travel distance overall (33.4 miles), those living in urban maternity care deserts also experienced inequities in travel distance (25.0 miles). States with hotspots indicating significantly higher travel distances included: Montana, North Dakota, South Dakota, and Nebraska. Census tracts where the predominant race is American Indian/Alaska Native (AIAN) had the highest travel distance and time compared to those of all other predominant races/ethnicities., Conclusions: Our study revealed significant disparities in obstetric hospital access, especially affecting birthing individuals in maternity care deserts, rural counties, and communities predominantly composed of AIAN individuals, resulting in extended travel distances and times. To rectify these inequities, sustained investment in the obstetric workforce and implementation of innovative programs are imperative, specifically targeting improved access in maternity care deserts as a priority area within healthcare policy and practice., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
24. Promoting the practice of exclusive breastfeeding: a philosophic scoping review.
- Author
-
Amoo TB, Popoola T, and Lucas R
- Subjects
- Female, Humans, Infant, Philosophy, World Health Organization, Breast Feeding psychology, Self Efficacy
- Abstract
Background: The World Health Organization recommends exclusive breastfeeding for the first 6 months of an infant's life and continued breastfeeding for 2 years. The global rate of exclusive breastfeeding is low at 33%. Thus, it is important to identify philosophical and theory-based strategies that can promote exclusive breastfeeding. The aim of the study was to identify philosophical schools of thought and theories used in research on promoting the practice of exclusive breastfeeding., Methods: A scoping review using Arksey and O'Malley's framework explored the phenomenon of exclusive breastfeeding practice promotion. Searches were conducted using CINAHL Plus full-text, PubMed, APA PsycInfo, and Academic Search Premier. Search terms included theory, philosophy, framework, model, exclusive breastfeeding, promotion, support, English, and publication between 2001-2022., Results: The online search yielded 1,682 articles, however, only 44 met the inclusion criteria for the scoping review. The articles promoting exclusive breastfeeding used pragmatism (n = 1) or phenomenology (n = 2) philosophies and theories of self-efficacy (n = 10), theory of planned behaviour (n = 13), social cognitive theories (n = 18) and represented 16 countries. Theories of self-efficacy and planned behaviour were the most used theories., Conclusions: This review suggests that theories and models are increasingly being used to promote exclusive breastfeeding. Orienting exclusive breastfeeding programmes within theoretical frameworks is a step in the right direction because theories can sensitize researchers and practitioners to contextually relevant factors and processes appropriate for effective exclusive breastfeeding strategies. Future research should examine the efficacy and effectiveness of theory-informed exclusive breastfeeding programmes over time. Such information is important for designing cost-effective EBF programmes., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
25. Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate to severe ARDS in a randomized, placebo-controlled, double-blind trial: preliminary evaluation of safety and feasibility in light of the COVID-19 pandemic.
- Author
-
Schmid B, Kranke P, Lucas R, Meybohm P, Zwissler B, and Frank S
- Subjects
- Double-Blind Method, Edema, Feasibility Studies, Humans, Pandemics, Peptides, Cyclic, Permeability, SARS-CoV-2, COVID-19 complications, Pulmonary Edema diagnosis, Pulmonary Edema drug therapy, Pulmonary Edema etiology, Respiratory Distress Syndrome diagnosis, Respiratory Distress Syndrome drug therapy
- Abstract
Background: In May 2018, the first patient was enrolled in the phase-IIb clinical trial "Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Edema in Patients with Moderate to Severe ARDS." With the onset of the COVID-19 pandemic in early 2020, the continuation and successful execution of this clinical study was in danger. Therefore, before the Data Safety Monitoring Board (DSMB) allowed proceeding with the study and enrollment of further COVID-19 ARDS patients into it, additional assessment on possible study bias was considered mandatory., Methods: We conducted an ad hoc interim analysis of 16 patients (5 COVID-19- ARDS patients and 11 with ARDS from different causes) from the phase-IIB clinical trial. We assessed possible differences in clinical characteristics of the ARDS patients and the impact of the pandemic on study execution., Results: COVID-19 patients seemed to be less sick at baseline, which also showed in higher survival rates over the 28-day observation period. Trial specific outcomes regarding pulmonary edema and ventilation parameters did not differ between the groups, nor did more general indicators of (pulmonary) sepsis like oxygenation ratio and required noradrenaline doses., Conclusion: The DSMB and the investigators did not find any evidence that patients suffering from ARDS due to SARS-CoV-2 may be at higher (or generally altered) risk when included in the trial, nor were there indications that those patients might influence the integrity of the study data altogether. For this reason, a continuation of the phase IIB clinical study activities can be justified. Researchers continuing clinical trials during the pandemic should always be aware that the exceptional circumstances may alter study results and therefore adaptations of the study design might be necessary., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
26. Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate-to-severe ARDS-a randomized, placebo-controlled, double-blind trial.
- Author
-
Schmid B, Kredel M, Ullrich R, Krenn K, Lucas R, Markstaller K, Fischer B, Kranke P, Meybohm P, Zwißler B, and Frank S
- Subjects
- Double-Blind Method, Edema, Humans, Peptides, Cyclic, Permeability, SARS-CoV-2, Treatment Outcome, COVID-19, Pulmonary Edema diagnosis, Pulmonary Edema drug therapy, Respiratory Distress Syndrome diagnosis, Respiratory Distress Syndrome drug therapy
- Abstract
Background: Acute respiratory distress syndrome (ARDS) is a complex clinical diagnosis with various possible etiologies. One common feature, however, is pulmonary permeability edema, which leads to an increased alveolar diffusion pathway and, subsequently, impaired oxygenation and decarboxylation. A novel inhaled peptide agent (AP301, solnatide) was shown to markedly reduce pulmonary edema in animal models of ARDS and to be safe to administer to healthy humans in a Phase I clinical trial. Here, we present the protocol for a Phase IIB clinical trial investigating the safety and possible future efficacy endpoints in ARDS patients., Methods: This is a randomized, placebo-controlled, double-blind intervention study. Patients with moderate to severe ARDS in need of mechanical ventilation will be randomized to parallel groups receiving escalating doses of solnatide or placebo, respectively. Before advancing to a higher dose, a data safety monitoring board will investigate the data from previous patients for any indication of patient safety violations. The intervention (application of the investigational drug) takes places twice daily over the course of 7 days, ensued by a follow-up period of another 21 days., Discussion: The patients to be included in this trial will be severely sick and in need of mechanical ventilation. The amount of data to be collected upon screening and during the course of the intervention phase is substantial and the potential timeframe for inclusion of any given patient is short. However, when prepared properly, adherence to this protocol will make for the acquisition of reliable data. Particular diligence needs to be exercised with respect to informed consent, because eligible patients will most likely be comatose and/or deeply sedated at the time of inclusion., Trial Registration: This trial was prospectively registered with the EU Clinical trials register (clinicaltrialsregister.eu). EudraCT Number: 2017-003855-47 ., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
27. Study protocol to investigate biomolecular muscle profile as predictors of long-term urinary incontinence in women with gestational diabetes mellitus.
- Author
-
Rudge MVC, Souza FP, Abbade JF, Hallur RLS, Marcondes JPC, Piculo F, Marini G, Vesentini G, Thabane L, Witkin SS, Calderon IMP, Barbosa AMP, Rudge MV, Barbosa AMP, Calderon IMP, Souza FP, Abbade JF, Hallur LSR, Piculo F, Marini G, Vesentini G, Thabane L, Palma MS, Graeff CFO, Arni RK, Herculano RD, Salvadori DF, Mateus S, Dal Pai Silva M, Magalhães CG, Costa RA, Lima SAM, Felisbino SL, Barbosa W, Atallah A, Girão MJB, Di Bella Z, Uchoa SM, Payão S, Hijas A, Berghman B, De Bie R, Sobrevia L, Junginger B, Alves FCB, Rossignoli PS, Prudencio CB, Orlandi MIG, Gonçalves MI, Nunes SK, Catinelli BB, Quiroz S, Sarmento BV, Pinheiro FA, Sartorão CI, Lucas RR, Reyes DRA, Quiroz SBCV, Enriquez EMA, Oliveira RG, Floriano JF, Marcondes JPC, Barneze S, Dangió TD, Pascon T, Rossignoli P, Freitas JV, Takano L, Reis F, Caldeirão TD, Fernandes JN, Carr AM, Gaitero MVC, Corrente JE, Nunes HRC, Candido AF, Costa SMB, Dangió TD, Pascon T, Melo JVF, Takano L, Reis FVDS, Caldeirão TD, Carr AM, Garcia GA, Rabadan GB, Bassin HCM, Suyama KS, Damasceno LN, Takemoto MLS, Menezes MD, Bussaneli DG, Nogueira VKC, Lima PR, Lourenço IO, Marostica de Sá J, Megid RA, Caruso IP, Rasmussen LT, Prata GM, Piculo F, Vesentini G, Arantes MA, Ferraz GAR, Camargo LP, Kron MR, Corrente JE, and Nunes HRC
- Subjects
- Adult, Brazil, Cesarean Section, Cohort Studies, Female, Gestational Age, Gestational Weight Gain, Humans, Maternal Age, Muscle Contraction physiology, Muscle Strength physiology, Palpation, Pelvic Floor physiopathology, Postpartum Period, Pregnancy, Rectus Abdominis physiopathology, Vagina, Diabetes, Gestational physiopathology, Muscular Diseases physiopathology, Urinary Incontinence physiopathology
- Abstract
Background: Pelvic floor muscles (PFM) and rectus abdominis muscles (RAM) of pregnant diabetic rats exhibit atrophy, co-localization of fast and slow fibers and an increased collagen type I/III ratio. However, the role of similar PFM or RAM hyperglycemic-related myopathy in women with gestational diabetes mellitus (GDM) remains poorly investigated. This study aims to assess the frequency of pelvic floor muscle disorders and pregnancy-specific urinary incontinence (PS-UI) 12 months after the Cesarean (C) section in women with GDM. Specifically, differences in PFM/RAM hyperglycemic myopathy will be evaluated., Methods: The Diamater is an ongoing cohort study of four groups of 59 pregnant women each from the Perinatal Diabetes Research Centre (PDRC), Botucatu Medical School (FMB)-UNESP (São Paulo State University), Brazil. Diagnosis of GDM and PS-UI will be made at 24-26 weeks, with a follow-up at 34-38 weeks of gestation. Inclusion in the study will occur at the time of C-section, and patients will be followed at 24-48 h, 6 weeks and 6 and 12 months postpartum. Study groups will be classified as (1) GDM plus PS-UI; (2) GDM without PS-UI; (3) Non-GDM plus PS-UI; and (4) Non-GDM without PS-UI. We will analyze relationships between GDM, PS-UI and hyperglycemic myopathy at 12 months after C-section. The mediator variables to be evaluated include digital palpation, vaginal squeeze pressure, 3D pelvic floor ultrasound, and 3D RAM ultrasound. RAM samples obtained during C-section will be analyzed for ex-vivo contractility, morphological, molecular and OMICS profiles to further characterize the hyperglycemic myopathy. Additional variables to be evaluated include maternal age, socioeconomic status, educational level, ethnicity, body mass index, weight gain during pregnancy, quality of glycemic control and insulin therapy., Discussion: To our knowledge, this will be the first study to provide data on the prevalence of PS-UI and RAM and PFM physical and biomolecular muscle profiles after C-section in mothers with GDM. The longitudinal design allows for the assessment of cause-effect relationships between GDM, PS-UI, and PFMs and RAMs myopathy. The findings may reveal previously undetermined consequences of GDM.
- Published
- 2020
- Full Text
- View/download PDF
28. Bio-production of gaseous alkenes: ethylene, isoprene, isobutene.
- Author
-
Wilson J, Gering S, Pinard J, Lucas R, and Briggs BR
- Abstract
To reduce emissions from petrochemical refinement, bio-production has been heralded as a way to create economically valuable compounds with fewer harmful effects. For example, gaseous alkenes are precursor molecules that can be polymerized into a variety of industrially significant compounds and have biological production pathways. Production levels, however, remain low, thus enhancing bio-production of gaseous petrochemicals for chemical precursors is critical. This review covers the metabolic pathways and production levels of the gaseous alkenes ethylene, isoprene, and isobutene. Techniques needed to drive production to higher levels are also discussed.
- Published
- 2018
- Full Text
- View/download PDF
29. Identifying classes of persons with mild intellectual disability or borderline intellectual functioning: a latent class analysis.
- Author
-
Nouwens PJG, Lucas R, Smulders NBM, Embregts PJCM, and van Nieuwenhuizen C
- Subjects
- Adolescent, Adult, Aged, Child, Child, Preschool, Disability Evaluation, Female, Humans, Intellectual Disability diagnosis, Learning Disabilities diagnosis, Male, Middle Aged, Young Adult, Intellectual Disability classification, Learning Disabilities classification
- Abstract
Background: Persons with mild intellectual disability or borderline intellectual functioning are often studied as a single group with similar characteristics. However, there are indications that differences exist within this population. Therefore, the aim of this study was to identify classes of persons with mild intellectual disability or borderline intellectual functioning and to examine whether these classes are related to individual and/or environmental characteristics., Methods: Latent class analysis was performed using file data of 250 eligible participants with a mean age of 26.1 (SD 13.8, range 3-70) years., Results: Five distinct classes of persons with mild intellectual disability or borderline intellectual functioning were found. These classes significantly differed in individual and environmental characteristics. For example, persons with a mild intellectual disability experienced fewer problems than those with borderline intellectual disability., Conclusions: The identification of five classes implies that a differentiated approach is required towards persons with mild intellectual disability or borderline intellectual functioning.
- Published
- 2017
- Full Text
- View/download PDF
30. An in vitro screening assay for dental stain cleaning.
- Author
-
Wang C, Lucas R, Smith AJ, and Cooper PR
- Subjects
- Animals, Cattle, Colorimetry, In Vitro Techniques, Materials Testing, Surface Properties, Dentifrices pharmacology, Tooth Discoloration therapy, Toothbrushing
- Abstract
Background: The present study aimed to develop an in vitro model for stain removal from natural enamel for the assessment and comparison of oral hygiene products., Methods: Bovine teeth (n = 8 per group) were ground/polished to provide flat enamel specimens and ferric-tannate deposits were precipitated onto the enamel surfaces. The ferric-tannate stained enamel specimens were brushed using an in vitro tooth-brushing simulator with slurries containing commercially available toothpaste products, dental abrasive particles, and sodium tripolyphosphate (STP) solutions of different concentrations. The colour of the enamel surfaces was measured using a spectrophotometer before and after stain application as well as after the brushing treatments., Results: Differences in stain removal efficacy were found between the toothpastes categorised as whitening and non-whitening comprising of different types of dental abrasives (hydrated silica and alumina). A mean value of 27% for stain removal was detected for the three non-whitening toothpastes and 59% of stain removal was detected for the three whitening toothpastes after 1000 strokes. Compared with the slurry with Zeodent 113 abrasive alone, the addition of STP provided better performance for stain removal under the same brushing conditions (mean value of 62% for Zeodent 113 abrasive alone and 72% with the addition of 5% (w/w) STP after 1000 strokes). No difference was evident between the STP concentration of 5% (w/w) and 10% (w/w)., Conclusions: The ferric-tannate/bovine enamel model reported here provides good stain retention, is rapidly and easily prepared, and is shown to be progressively and reproducibly sensitive to toothbrushing using different toothpastes and surfactant/chelating agent solutions. Importantly, it provides good discrimination between various oral hygiene products. The stain removal assay reported here has considerable potential to enable comparative assessments of different toothpaste types in terms of their cleaning capabilities.
- Published
- 2017
- Full Text
- View/download PDF
31. Acute appendicitis: transcript profiling of blood identifies promising biomarkers and potential underlying processes.
- Author
-
Chawla LS, Toma I, Davison D, Vaziri K, Lee J, Lucas R, Seneff MG, Nyhan A, and McCaffrey TA
- Subjects
- Acute Disease, Adult, Appendicitis diagnostic imaging, Biomarkers blood, Female, Humans, Male, Middle Aged, Tomography, X-Ray Computed, Appendicitis blood, Appendicitis genetics, Computational Biology methods, Gene Expression Profiling
- Abstract
Background: The diagnosis of acute appendicitis can be surprisingly difficult without computed tomography, which carries significant radiation exposure. Circulating blood cells may carry informative changes in their RNA expression profile that would signal internal infection or inflammation of the appendix., Methods: Genome-wide expression profiling was applied to whole blood RNA of acute appendicitis patients versus patients with other abdominal disorders, in order to identify biomarkers of appendicitis. From a large cohort of emergency patients, a discovery set of patients with surgically confirmed appendicitis, or abdominal pain from other causes, was identified. RNA from whole blood was profiled by microarrays, and RNA levels were filtered by a combined fold-change (>2) and p value (<0.05). A separate set of patients, including patients with respiratory infections, was used to validate a partial least squares discriminant (PLSD) prediction model., Results: Transcript profiling identified 37 differentially expressed genes (DEG) in appendicitis versus abdominal pain patients. The DEG list contained 3 major ontologies: infection-related, inflammation-related, and ribosomal processing. Appendicitis patients had lower level of neutrophil defensin mRNA (DEFA1,3), but higher levels of alkaline phosphatase (ALPL) and interleukin-8 receptor-ß (CXCR2/IL8RB), which was confirmed in a larger cohort of 60 patients using droplet digital PCR (ddPCR)., Conclusions: Patients with acute appendicitis have detectable changes in the mRNA expression levels of factors related to neutrophil innate defense systems. The low defensin mRNA levels suggest that appendicitis patient's immune cells are not directly activated by pathogens, but are primed by diffusible factors in the microenvironment of the infection. The detected biomarkers are consistent with prior evidence that biofilm-forming bacteria in the appendix may be an important factor in appendicitis.
- Published
- 2016
- Full Text
- View/download PDF
32. Geographical distribution of Amblyomma cajennense (sensu lato) ticks (Parasitiformes: Ixodidae) in Brazil, with description of the nymph of A. cajennense (sensu stricto).
- Author
-
Martins TF, Barbieri AR, Costa FB, Terassini FA, Camargo LM, Peterka CR, de C Pacheco R, Dias RA, Nunes PH, Marcili A, Scofield A, Campos AK, Horta MC, Guilloux AG, Benatti HR, Ramirez DG, Barros-Battesti DM, and Labruna MB
- Subjects
- Animals, Brazil, Cluster Analysis, DNA, Ribosomal Spacer chemistry, DNA, Ribosomal Spacer genetics, Nymph anatomy & histology, Phylogeny, Sequence Analysis, DNA, Ixodidae anatomy & histology, Ixodidae growth & development, Phylogeography
- Abstract
Background: Until recently, Amblyomma cajennense (Fabricius, 1787) was considered to represent a single tick species in the New World. Recent studies have split this taxon into six species. While the A. cajennense species complex or A. cajennense (sensu lato) (s.l.) is currently represented by two species in Brazil, A. cajennense (sensu stricto) (s.s.) and Amblyomma sculptum Berlese, 1888, their geographical distribution is poorly known., Methods: The distribution of the A. cajennense (s.l.) in Brazil was determined by morphological examination of all lots of A. cajennense (s.l.) in two large tick collections of Brazil, and by collecting new material during three field expeditions in the possible transition areas between the distribution ranges of A. cajennense (s.s.) and A. sculptum. Phylogenetic analysis inferred from the ITS2 rRNA gene was used to validate morphological results. Morphological description of the nymphal stage of A. cajennense (s.s.) is provided based on laboratory-reared specimens., Results: From the tick collections, a total 12,512 adult ticks were examined and identified as 312 A. cajennense (s.s.), 6,252 A. sculptum and 5,948 A. cajennense (s.l.). A total of 1,746 ticks from 77 localities were collected during field expeditions, and were identified as 249 A. cajennense (s.s.), 443 A. sculptum, and 1,054 A. cajennense (s.l.) [these A. cajennense (s.l.) ticks were considered to be males of either A. cajennense (s.s.) or A. sculptum]. At least 23 localities contained the presence of both A. cajennense (s.s.) and A. sculptum in sympatry. DNA sequences of the ITS2 gene of 50 ticks from 30 localities confirmed the results of the morphological analyses. The nymph of A. cajennense (s.s.) is morphologically very similar to A. sculptum., Conclusion: Our results confirmed that A. cajennense (s.l.) is currently represented in Brazil by only two species, A. cajennense (s.s.) and A. sculptum. While these species have distinct distribution areas in the country, they are found in sympatry in some transition areas. The current distribution of A. cajennense (s.l.) has important implications to public health, since in Brazil A. sculptum is the most important vector of the bacterium Rickettsia rickettsii, the etiological agent of Brazilian spotted fever.
- Published
- 2016
- Full Text
- View/download PDF
33. Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients.
- Author
-
de Lucas R, Moreno-Arias G, Perez-López M, Vera-Casaño Á, Aladren S, and Milani M
- Subjects
- Anti-Bacterial Agents therapeutic use, Anti-Infective Agents, Local therapeutic use, Chemotherapy, Adjuvant, Emollients therapeutic use, Female, Humans, Male, Prospective Studies, Retinoids therapeutic use, Severity of Illness Index, Skin Cream therapeutic use, Soaps therapeutic use, Treatment Outcome, Young Adult, Acne Vulgaris drug therapy, Dermatologic Agents therapeutic use, Medication Adherence
- Abstract
Background: In acne, several studies report a poor adherence to treatments. We evaluate, in a real-life setting conditions, the impact of compliance to physician's instructions, recommendations and adherence to the treatments on clinical outcome in patients with mild to moderate acne in an observational, non-interventional prospective study carried out in 72 Dermatologic Services in Spain (ACTUO Trial)., Methods: Six-hundred-forty-three subjects were enrolled and 566 patients (88 %) completed the 3 study visits. Study aimed to evaluate the impact of adherence (assessed with ECOB scale) on clinical outcome, as well as how the use of specific adjuvant treatments (facial cleansing, emollient, moisturizing and lenitive specific topical products) influences treatment's adherence and acne severity (0-5 points score). Recommendation of specific adjuvant skin barrier repair products was made in 85.2 %., Results: Overall, clinical improvement was observed throughout follow-up visits with an increased proportion of patients who reported reductions of ≥50 % on the total number of lesions (2 months: 25.2 %; 3 months: 57.6 %) and reductions of severity scores (2.5, 2.0 and 1.3 at 1, 2 and 3 months after treatment, respectively). Adherence to treatment was associated with a significant reduction on severity grading, a lower number of lesions and a higher proportion of patients with ≥50 % improvement., Conclusions: Good adherence to medication plus adherence to adjuvants was significantly associated with a higher clinical improvement unlike those that despite adherence with medication had a low adherence to adjuvants. A good adherence to adjuvant treatment was associated with improved adherence and better treatment outcomes in mild to moderate acne patients. (ISRCTN Registry: ISRCTN14257026).
- Published
- 2015
- Full Text
- View/download PDF
34. Osteoarthritis medical labelling and health-related quality of life in the general population.
- Author
-
Lourenço S, Lucas R, Araújo F, Bogas M, Santos RA, and Barros H
- Subjects
- Adult, Aged, Female, Humans, Middle Aged, Psychometrics, Self Report, Depressive Disorder psychology, Osteoarthritis psychology, Quality of Life, Stereotyping
- Abstract
Background: Osteoarthritis is the most common chronic joint disease. In the absence of an effective medical treatment and due to the chronic nature of this condition, an osteoarthritis medical diagnosis may finally result in decreased health-related quality of life. Therefore, the aim of this study was to measure the impact of the osteoarthritis medical labelling on physical and mental health-related quality of life., Methods: Subjects (n = 1132, 58.7% women) were approached as participants of an urban population-based cohort (EPIPorto). Self-reported information on previous diagnosis of knee, hip or hand osteoarthritis was obtained and rheumatologists established knee, hip or hand osteoarthritis clinical diagnosis in symptomatic individuals. Physical and mental dimensions of health-related quality of life were evaluated using the self-administered Medical Outcomes Study: 36-Item Short Form Survey. Crude and adjusted linear regression coefficients (beta) and the corresponding 95% confidence intervals (95% CI) were computed to estimate the associations between being labelled as an osteoarthritis case and health-related quality of life., Results: Regardless of disease medical labelling, individuals with osteoarthritis scored significantly lower physical health-related quality of life when compared to those without joint disease (kneeunexposed: beta = -5.3, 95% CI: -7.6, -3.1; kneeexposed: beta = -6.0, 95% CI: -8.4, -3.7; hipunexposed: beta = -6.0, 95% CI: -9.8, -2.3; hipexposed: beta = -11.0, 95% CI: -15.6, -6.4; handunexposed: beta = -4.3, 95% CI: -6.5, -2.0; handexposed: beta = -4.3, 95% CI: -6.6, -2.1). The same was not observed regarding mental health-related quality of life. Among subjects with clinically confirmed osteoarthritis, the medical labelling of this joint disease was not significantly associated to health-related quality of life., Conclusions: The labelling of knee, hip and hand osteoarthritis diagnosis may not add specific benefit to osteoarthritis patients in terms of its capability to improve health-related quality of life.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.